Early-Onset Osteopenia and Osteoporosis in Patients with Pyruvate Kinase Deficiency
Hanny Al‐Samkari(Harvard University), Eduard J. van Beers(Utrecht University), Rachael F. Grace(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Wilma Barcellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), John B. Porter(Royal London Hospital), Chris Bowden(Agios Pharmaceuticals (United States)), Oliver Andrés(University of Würzburg), Kevin H.M. Kuo(University Health Network), Yan Dong(Tulane University), Sarah Gheuens(Biogen (United States)), Marta Morado(Hospital Universitario La Paz), Frederic Galactéros(Inserm), Peter Hawkins(Agios Pharmaceuticals (United States)), Vip Viprakasit(Siriraj Hospital), Andreas Glenthoej(Herlev Hospital), Feng Tai(Agios Pharmaceuticals (United States)), D. Mark Layton(Imperial College Healthcare NHS Trust)
Cited by 5
Related Papers
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
|Neuromuscular Disorders|2019|636
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
|Blood|2014|373
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
|New England Journal of Medicine|2020|320
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
|New England Journal of Medicine|2022|309